Budesonide warrants consideration for treating acute exacerbations of inflammatory bowel disorders

Drugs and Therapy Perspectives

Volumn 7, Issue 9, 1996, Pages 1-6

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; ENEMA; HYDROCORTISONE; IMMUNOMODULATING AGENT; MESALAZINE; METHYLPREDNISOLONE; OLSALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ANTIINFLAMMATORY ACTIVITY; CLINICAL PRACTICE; CLINICAL TRIAL; CROHN DISEASE; CUSHINGOID SYNDROME; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG THERAPY; ENTERITIS; GASTROINTESTINAL SYMPTOM; HUMAN; HYDROCORTISONE BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; PRESCRIPTION; PREVENTION; RECTAL DRUG ADMINISTRATION; RELAPSE; REMISSION; SHORT SURVEY; SUSTAINED RELEASE PREPARATION; ULCERATIVE COLITIS;

EID: 0029994124     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-199607090-00001     Document Type: Short Survey

References (23)

1. Scott AJ. Ulcerative colitis and Crohn's disease. In: Speight T, Sutherland J, editors. New Ethicals Disease Index. 4th ed. Auckland, New Zealand: Adis International, 1995: 223-7
2. Lennard-Jones JE. Treatment of inflammatory bowel disease - future directions. Res Clin Forum 1995; 17 (1): 223-34
3. Spencer CM, McTavish D. Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease. Drugs 1995; 50 (5), 854-72
4. de Kaski MC, Hodgson HJF. Rolling review: inflammatory bowel disease. Aliment Pharmacol Ther 1993; 7: 567-79
5. Clissold SP, Heel RC. Budesonide: a preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis. Drugs 1984; 28: 485-518
6. British National Formulary No. 30. London: The Pharmaceutical Press, 1995 Sep.
7. Bianchi Porro G, Prantera C, Campieri M, et al. Comparative trial of methylprednisolone and budesonide enemas in active distal ulcerative colitis. Eur J Gastroenterol Hepatol 1994; 6: 125-30
8. Löfberg R, Østergaard Thomsen O, Langholz E, et al. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther 1994 Dec; 8: 591-5
9. Löfberg R, Danielsson Å, Nilsson Å, et al. Oral budesonide is comparable to prednisolone in active ulcerative colitis but causes no suppression of plasma cortisol [abstract 1787P]. 10th Congress of Gastroenterology October 207, 1994
10. Lamers C, Meijer J, Engels, et al. Comparative study of the topically acting glucocorticosteroid budesonide and 5-aminosalicylic acid enema therapy of proctitis and proctosigmoiditis [abstract]. Gastroenterology 1991: 100 (5): A223
11. Lemann M, Rutgeerts P, van Heuvertzwijn R, et al. Comparison of budesonide enema and 5-ASA enema in the treatment of active distal ulcerative colitis [abstract]. 1st United European Gastroenterology Week, Athens, Sep 25-27, 1991
12. Caesar I, Gross V, Roth M, et al. Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Z Gastroenterol 1995; 33: 247-50
13. Löfberg R, Danielsson Å, Salde L. Oral budesonide in active Crohn's disease. Aliment Pharmacol Ther 1993 Dec; 7: 611-616
14. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Gastroenterology 1996; 110(1): 45-51
15. Löfberg R, Rutgeerts P, Malchow H. Budesonide CIR for maintenance of remission in ileocecal Crohn's disease. A European multicenter placebo controlled trial for 12 months [abstract no. 90]. 10th World Congress of Gastroenterology 1994: 13
16. Tarpila S, Turunen U, Seppälä K, et al. Budesonide enema in active haemorrhagic proctitis - a controlled trial against hydrocortisone foam enema. Aliment Pharmacol Ther 1994 Dec; 8: 591-5
17. Rutgeerts P, Löfberg R, Malchow H. et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994 Sep 29; 331: 842-845
18. Campieri M, Ferguson A, Doe W, et al. Oral budesonide competes favourably with prednisolone in active Crohn's disease [abstract]. Gastroenterology 1995; 108 (4) Suppl.: A790
19. Gross V, Andus T, Caesar I, et al. Oral pH-modified release budesonide vs 6-methylprednisolone in active Crohn's disease [abstract]. Gastroenterology 1995; 108(4) Suppl.: A828
20. Danish Budesonide Study Group. Budesonide enema in distal ulcerative colitis. A randomised dose-response trial with prednisolone enema as active control. Scand J Gastroenterol 1991; 26: 1225-30
21. Greenberg GR, Feagan BG, Martin F. Oral budesonide for active Crohn's disease. N Engl J Med 1994 Sep 29; 331: 836-41
22. What place has oral budesonide in Crohn's disease? Pharm J 1996 Mar 16; 256: 372
23. D'Haens GR, Rutgeerts PJ. How should corticosteroids be used in inflammatory bowel disease. Clin Immunother 1996 May; 5(5): 334-40